Hyperfine, Inc. (NASDAQ:HYPR – Get Free Report) shares dropped 1.1% on Wednesday . The company traded as low as $0.80 and last traded at $0.81. Approximately 69,428 shares were traded during trading, a decline of 2% from the average daily volume of 70,499 shares. The stock had previously closed at $0.82.
Analyst Ratings Changes
Separately, Wells Fargo & Company decreased their price target on shares of Hyperfine from $2.10 to $1.60 and set an “equal weight” rating on the stock in a research note on Friday, March 22nd.
Get Our Latest Research Report on HYPR
Hyperfine Stock Down 1.1 %
Hyperfine (NASDAQ:HYPR – Get Free Report) last issued its quarterly earnings data on Thursday, March 21st. The company reported ($0.15) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.17) by $0.02. The company had revenue of $2.69 million during the quarter, compared to analysts’ expectations of $3.66 million. Hyperfine had a negative return on equity of 44.89% and a negative net margin of 401.00%. Analysts predict that Hyperfine, Inc. will post -0.53 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
Institutional investors have recently made changes to their positions in the business. Citigroup Inc. bought a new position in shares of Hyperfine in the third quarter valued at about $29,000. Knollwood Investment Advisory LLC bought a new position in shares of Hyperfine in the third quarter valued at about $41,000. EP Wealth Advisors LLC bought a new position in shares of Hyperfine in the third quarter valued at about $71,000. Journey Strategic Wealth LLC bought a new position in shares of Hyperfine in the fourth quarter valued at about $84,000. Finally, Signaturefd LLC bought a new position in shares of Hyperfine in the third quarter valued at about $102,000. 15.03% of the stock is owned by institutional investors.
Hyperfine Company Profile
Hyperfine, Inc, a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors.
Recommended Stories
- Five stocks we like better than Hyperfine
- How to Find Undervalued Stocks
- High-Yield Texas Instruments Could Hit New Highs Soon
- Are Penny Stocks a Good Fit for Your Portfolio?
- Pagaya Technologies: An AI Fintech That Insiders Are Buying
- Investing In Automotive Stocks
- Higher Oil Prices Could Give NextEra’s Stock Earnings a Boost
Receive News & Ratings for Hyperfine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hyperfine and related companies with MarketBeat.com's FREE daily email newsletter.